Aristotle University Of Thessaloniki (AUTH)
Η συμβολή του δείκτη κάθαρσης πνευμόνων LCI στην εκτίμηση παιδιών με χρόνιες πνευμονοπάθειες
Abstract
dc:descriptionAssessment methods for children with chronic lung diseases, such as Cystic Fibrosis (CF) and Non-CF Bronchiectasis (NCFB), are of great importance. Ventilation inhomogeneity is a common feature of the above diseases and can be assessed by Lung Clearance Index (LCI). This study aims to investigate in depth the contribution of LCI in assessing children with chronic lung diseases. Findings suggest that LCI values of CF patients and NCFB patients are significantly higher compared to healthy controls’; and they demonstrate consistency between the two patient groups. Considering that generally LCI remains stable in children, LCI values increased significantly over time among CF patients. Additionally, LCI values in adolescents were significantly higher than LCI values of school age and preschool children. Regarding the isolated pathogens from cough swab cultures, patients positive to Pseudomonas aeruginosa (PsA) had significantly higher LCI than patients negative to PsA. Of note is that the LCI value was significantly deteriorated during first isolation of Pseudomonas aeruginosa from cough swab. In comparison to other methods for assessing chronic lung disease: a) LCI proved a more sensitive index than Spirometry in early stages, as 47.6% of patients with normal FEV1 had abnormal LCI; b) In comparison to HRCT, the gold standard method for lung structure damages detection, LCI was strongly correlated with the Bhalla score; c) LCI showed good agreement with a lot of parameters of exercise testing. In particular, it demonstrated negative correlation with the mean peak oxygen uptake during exercise (VO2peak%) and breathing reserve (BR%) and positive correlation with Ventilation (VE) and the ventilatory equivalents (VE/VO2 and VE/VCO2). The absolute annual change of LCI was 0.88 among patients with CF. It was also shown that the change is different among three age groups (adolescents > school age children > preschoolers); and is higher in patients colonized with Pseudomonas aeruginosa. The percentage annual change of LCI could be estimated 4.96% per year. Further findings suggest that LCI deteriorates significantly during a pulmonary exacerbation and the index was also proved as the unique independent predictor of a pulmonary exacerbation. Finally, LCI was evaluated as an assessment tool for the efficacy of therapeutic interventions: a) LCI improved significantly one month after intravenous anti-pseudomonas antibiotic treatment among CF patients and the improvement was tremendous among patients receiving the regimen to cope with a pulmonary exacerbation as opposed to those receiving the regimen to Pseudomonas aeruginosa eradication; b) Chronic treatment with inhaled Tobramycin did not modify LCI values, while LCI values in three 3 times [t0: before Tobramycin treatment, t1: at the end of the first month of study (Tobramycin on), t2: at the end of the second month of study (Tobramycin off)], did not differ significantly. In conclusion, LCI can be considered as a valuable index for monitoring children with chronic lung diseases as it can be used to assess the severity and progression of the disease; to predict a pulmonary exacerbation and the first isolation of Pseudomonas aeruginosa; and to evaluate treatment interventions.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Avramidou, Vasiliki
- Αβραμίδου, Βασιλική
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/44160